Phenethylamine

Phenethylamine

SCHEMBL245154

Cl.NCCc1ccccc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phenethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 3/20 0.94
MAOB known ✓ P27338 4/20 0.64
MAOA known ✓ P21397 3/20 0.64
HTR6 known ✓ P50406 2/20 0.56
HTR2C known ✓ P28335 1/20 0.54
LOXL2 Q9Y4K0 2/20 0.94
CYP2A6 P11509 1/20 0.94
SMN1; SMN2 Q16637 1/20 0.94
TAAR1 Q96RJ0 1/20 0.94
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
BLM P54132 1/20 0.56
KMT2A Q03164 1/20 0.56
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenethylamine SCHEMBL11664723 0.97 HTR2A (0.89) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1
Phenethylamine SCHEMBL29277512 0.97 HTR2A (0.89) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1
Phenethylamine SCHEMBL16294846 0.97 HTR2A (0.89) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1
Phenethylamine SCHEMBL1332244 0.97
Phenethylamine SCHEMBL1799333 0.97 HTR2A (1.00) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1
Phenethylamine SCHEMBL27634208 0.97 HTR2A (1.00) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1
Phenethylamine SCHEMBL1331271 0.97
Phenethylamine SCHEMBL968 0.97
Phenethylamine SCHEMBL1330939 0.97
Phenethylamine SCHEMBL5306641 0.94 HTR2A (0.94) HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1085 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122081951-A Corrosion inhibitor for circulating water of coastal high-chlorine environment steel mill and preparation method thereof 2026-05-26 CN claimed
US-20260101625-A1 PEROVSKITE SOLAR CELL AND ITS PREPARATION UNIV CITY HONG KONG (HK) 2026-04-09 US claimed
US-20250277127-A1 PEROVSKITE INK FOR SCALABLE FABRICATION OF EFFICIENT AND STABLE PEROVSKITE MODULES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2025-09-04 US claimed
CN-120166840-A Mixed halogen perovskite photovoltaic device based on mesophase regulation and control and preparation method thereof 河北大学 2025-06-17 CN claimed
CN-119320637-B Composition for preparing deep blue light quasi two-dimensional perovskite and application thereof 五邑大学 2025-06-13 CN claimed
CN-120076686-A Perovskite film, preparation method thereof and solar cell 中国华能集团清洁能源技术研究院有限公司 2025-05-30 CN claimed
CN-120018742-A Perovskite surface sequential post-treatment method based on two-dimensional ligand modification materials with different polarities 武汉理工大学 2025-05-16 CN claimed
CN-119907603-A Efficient trans-perovskite solar cell and preparation method thereof 深圳北理莫斯科大学 2025-04-29 CN claimed
CN-119907609-A Solar cell, preparation method thereof, electric equipment and power generation equipment 天合光能股份有限公司 2025-04-29 CN claimed
CN-119855350-A Perovskite solar cell, preparation method thereof, solar cell module and electricity utilization device 比亚迪股份有限公司 2025-04-18 CN claimed
EP-1169515-A1 SIZING COMPOSITION AKZO NOBEL N.V. (NL) 2002-01-09 EP claimed
WO-2000063493-A1 SIZING COMPOSITION AKZO NOBEL N.V. (NL) 2000-10-26 WO claimed
EP-0963484-A1 SIZING OF PAPER AKZO NOBEL N.V. (NL) 1999-12-15 EP claimed
EP-0951284-A1 PHENYLETHYLAMINE DERIVATIVES TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1999-10-27 EP claimed
WO-1998033979-A1 SIZING OF PAPER AKZO NOBEL N.V. (NL) 1998-08-06 WO claimed
WO-1998026775-A1 PHENYLETHYLAMINE DERIVATIVES TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1998-06-25 WO claimed
EP-0358856-A2 Novel insecticidal dibenzoyl-tert-butylcarbanonitrile compounds and method for the preparation thereof AMERICAN CYANAMID COMPANY (US) 1990-03-21 EP claimed
US-4857550-A Novel insecticidal dibenzoyl-tert-butylcarbazonitrile compounds and method for the preparation thereof AMERICAN CYANAMID COMPANY (US) 1989-08-15 US claimed
US-4169943-A PROCESS FOR THE PREPARATION OF AMINO DERIVATIVES OF N-HETEROCYCLES SCHERING AKTIENGESELLSCHAFT (DE) 1979-10-02 US claimed
US-4076765-A MOLDING MATERIALS, CONSTRUCTION MATERIALS SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-02-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260101625-A1 PEROVSKITE SOLAR CELL AND ITS PREPARATION NES, PPOX, SCO2 HTR2A 3595/4885MAOB 3623/4885MAOA 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.